ADC Therapeutics SA (ADCT)

NYSE: ADCT · IEX Real-Time Price · USD
0.13 (1.79%)
May 27, 2022 4:00 PM EDT - Market closed

Total Valuation

ADCT has a market cap or net worth of $567.63 million. The enterprise value is $261.41 million.

Market Cap567.63M
Enterprise Value261.41M

Important Dates

The latest earnings date was Monday, May 9, 2022, before market open.

Last Earnings DateMay 9, 2022
Ex-Dividend Daten/a

Share Statistics

ADCT has 76.81 million shares outstanding. The number of shares has increased by 0.12% in one year.

Shares Outstanding76.81M
Shares Change (YoY)+0.12%
Shares Change (QoQ)+0.09%
Owned by Insiders (%)52.35%
Owned by Institutions (%)45.88%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio7.06
PB Ratio3.49
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales3.25
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 6.89, with a Debt / Equity ratio of 0.77.

Current Ratio6.89
Quick Ratio6.47
Debt / Equity0.77
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -102.70%, which is considered low. The company has a ROIC of -129.40%.

Return on Equity (ROE)-102.70%
Return on Assets (ROA)-33.90%
Return on Capital (ROIC)-129.40%
Revenue Per Employee$257,740
Profits Per Employee-$625,513
Employee Count312
Asset Turnover0.14
Inventory Turnovern/a


Income Tax-22.76M
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -67.39% in the last 52 weeks. The beta is 1.85, so ADCT's price volatility has been higher than the market average.

Beta (1Y)1.85
52-Week Price Change-67.39%
50-Day Moving Average10.38
200-Day Moving Average16.19
Average Volume (30 Days)211,741

Short Selling Information

The latest short interest is 6.04 million, so 7.86% of the outstanding shares have been sold short.

Short Interest6.04M
Short % of Shares Out7.86%
Short % of Float20.92%
Short Ratio (days to cover)36.80

Income Statement

In the last 12 months, ADCT had revenue of $80.42 million and -195.16 million in losses. Earnings per share was -$2.54.

Gross Profit78.49M
Operating Income-231.42M
Pretax Income-217.92M
Net Income-195.16M
Earnings Per Share (EPS)-$2.54
Full Income Statement

Balance Sheet

The company has $430.87 million in cash and $124.65 million in debt, giving a net cash position of $306.22 million or $3.99 per share.

Cash & Cash Equivalents430.87M
Total Debt124.65M
Net Cash306.22M
Net Cash Per Share$3.99
Book Value162.67M
Book Value Per Share2.12
Working Capital416.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$204.22 million and capital expenditures -$3.89 million, giving a free cash flow of -$208.11 million.

Operating Cash Flow-204.22M
Capital Expenditures-3.89M
Free Cash Flow-208.11M
FCF Per Sharen/a
Full Cash Flow Statement


Gross margin is 97.61%, with operating and profit margins of -287.78% and -242.69%.

Gross Margin97.61%
Operating Margin-287.78%
Pretax Margin-270.99%
Profit Margin-242.69%
EBITDA Margin-304.45%
EBIT Margin-307.74%
FCF Margin-258.79%

Dividends & Yields

ADCT does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-34.38%
FCF Yield-36.66%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Dividend Details

Analyst Forecast

The average price target for ADCT is $32.81, which is 343.98% higher than the current price. The consensus rating is "Buy".

Price Target$32.81
Price Target Difference343.98%
Analyst ConsensusBuy
Analyst Count14
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a